Optinose Inc Revenue per Employee (OPTN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Optinose Inc   (NASDAQ: OPTN)
 

Optinose Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 83.27% in the first quarter 2025, year on year to cumulative value of $91 million, Optinose Inc 's revenue per employee grew on a trailing twelve months basis to $ 450,826, this marks a new company high.
Within the Healthcare sector Employees of 201 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1506, from total ranking in previous quarter at 2172. Optinose Inc has 201 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OPTN Revenue per Employee (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Revenue Change 83.27 % 12.86 % 3.1 % 5.33 % 25.61 %
Sales per Employee (TTM) $ 450,826 389,184 376,473 373,418 368,264
OPTN's Total Ranking # 1506 # 2172 # 2263 # 0 # 0
Seq. Revenue Change 21.64 % 9.7 % -0.26 % 37.7 % -25.09 %

OPTN Company Profile >> Back to OPTN Efficiency Comparisons >> Compare OPTN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 108
Healthcare Sector # 202
Overall Market # 1506

Revenue per Employee Statistics
High Average Low
$ 450,826 $ 292,840 $ -172,294
(Mar 31 2025)   (Dec 31 2018)



Financial Statements
Optinose Inc 's Revenue MRQ $ 27 Millions Visit OPTN's Income Statement
Optinose Inc 's Revenues TTM $ 91 Millions Visit OPTN's aggregate revenue growth
What are OPTN's Sales? Visit OPTN's Sales by Segment




Other Ratios
Optinose Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OPTN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OPTN's Competitors
Revenue per Employee for OPTN's Suppliers
Revenue per Employee for OPTN's Customers

You may also want to know
OPTN's Sales Growth Rates OPTN's Pe Price to earnings ratio OPTN's Receivables Turnover Ratio OPTN's Stock Quote
OPTN's Net Income Growth Rates OPTN's Ps Price to Sales ratio OPTN's Sales per Employee OPTN's Asset Turnover Ratio
OPTN's Net Margin OPTN's Pb Price to Book ratio OPTN's Financial Strength Ratios OPTN's Dividend Payout Ratio
Date modified: 2026-08-29T17:41:32+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2025Number of Employees Mar 31 2025
Gossamer Bio Inc   769,074.07 $ 124.590  Million 162 
Inmed Pharmaceuticals Inc  752,556.33 $ 4.515  Million 6 
Precision Biosciences Inc  752,073.53 $ 51.141  Million 68 
Fortress Biotech Inc   740,820.51 $ 57.784  Million 78 
Ardelyx inc   739,685.07 $ 361.706  Million 489 
Alkermes Plc   738,424.39 $ 1,513.770  Million 2,050 
Hims and Hers Health Inc   730,437.76 $ 1,783.729  Million 2,442 
Adaptimmune Therapeutics Plc  730,239.84 $ 179.639  Million 246 
Vaxart Inc   729,153.85 $ 47.395  Million 65 
Theravance Biopharma inc   725,177.78 $ 65.266  Million 90 
Sunshine Biopharma Inc   724,691.56 $ 36.235  Million 50 
Dyadic International Inc   710,868.80 $ 3.554  Million 5 
Adma Biologics Inc   707,508.50 $ 457.758  Million 647 
Alphatec Holdings Inc   703,074.48 $ 641.907  Million 913 
X4 Pharmaceuticals Inc  696,977.78 $ 31.364  Million 45 
Ani Pharmaceuticals Inc  694,915.46 $ 674.068  Million 970 
Allurion Technologies Inc   678,000.00 $ 27.798  Million 41 
Moderna Inc   675,957.45 $ 3,177.000  Million 4,700 
Zevra Therapeutics Inc   665,377.05 $ 40.588  Million 61 
Sanuwave Health Inc   658,000.00 $ 36.190  Million 55 
Biofrontera Inc   647,815.22 $ 59.599  Million 92 
Zoetis Inc   640,413.79 $ 9,286.000  Million 14,500 
Cerus Corporation  637,756.94 $ 183.674  Million 288 
Immunocore Holdings Plc  636,604.96 $ 333.581  Million 524 
Sensus Healthcare Inc   635,366.67 $ 38.122  Million 60 
Johnson and Johnson  634,453.13 $ 89,331.000  Million 140,800 
Tarsus Pharmaceuticals Inc   631,551.35 $ 233.674  Million 370 
Tvardi Therapeutics Inc   630,916.67 $ 7.571  Million 12 
Inspire Medical Systems inc   629,537.13 $ 839.173  Million 1,333 
Organon and Co   629,400.00 $ 6,294.000  Million 10,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.